Edinburgh Research and Innovation is seeking partners to commercialise the next generation of malaria drugs and vaccine.
Edinburgh University has announced that it has identified a key protein that could prove the turning point in the fight against malaria. The University’s commercialisation unit, Edinburgh Research and Innovation, is now actively seeking investment partners in order to commercialise the research into an effective drug or vaccine. Researchers at Edinburgh’s School of Biological Sciences…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
